KAUST President announced a mandatory COVID-19 screening program for employees and students from November 1-5. The program aims to provide snapshots of COVID-19 prevalence in the community to inform healthcare demands and future plans. The university targets 5,000 individual swabs in partnership with the Ministry of Health, and participation is crucial for the program's success. Why it matters: This proactive measure enables KAUST to maintain a safe environment and continue reopening the campus, setting an example for managing the pandemic sustainably in the region.
A KAUST-led team developed NIRVANA, a portable, briefcase-sized device for rapid detection and sequencing of SARS-CoV-2, influenza, and other viruses. The test utilizes isothermal recombinase amplification (RPA) and was validated on clinical samples and wastewater. NIRVANA can differentiate SARS-CoV-2 strains and doesn't require expensive infrastructure. Why it matters: This innovation enables rapid, decentralized virus detection and surveillance, crucial for pandemic response and monitoring new variants across the region.
IFM has released K2-V2, a 70B-class LLM that takes a "360-open" approach by making its weights, data, training details, checkpoints, and fine-tuning recipes publicly available. K2-V2 matches leading open-weight model performance while offering full transparency, contrasting with proprietary and semi-open Chinese models. Independent evaluations show K2 as a high-performance, fully open-source alternative in the AI landscape. Why it matters: K2-V2 provides developers with a transparent and reproducible foundation model, fostering trust and enabling customization without sacrificing performance, which is crucial for sensitive applications in the region.